TSCAN THERAPEUTICS INC (TCRX) Stock Analyst Earnings Estimates
NASDAQ:TCRX - Nasdaq - US89854M1018 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.14M 830.28% | 13.54M 33.53% | 21.049M 55.46% | 3.541M -83.18% | 3.723M 5.14% | 8.129M 118.35% | 31.082M 282.36% | 70.707M 127.49% | 151.99M 114.96% | 266.7M 75.47% | 543.16M 103.66% | 660.17M 21.54% | |
| EBITDA YoY % growth | -45.31M -81.24% | -61.5M -35.73% | -88.097M -43.25% | -128.737M -46.13% | -138.838M -7.85% | -157.867M -13.71% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -48.64M -85.44% | -66.64M -37.01% | -93.458M -40.24% | -134.657M -44.08% | -150.234M -11.57% | -167.991M -11.82% | -141.075M 16.02% | -134.582M 4.60% | -76.02M 43.51% | 21.445M 128.21% | 244.39M 1,039.61% | 328.57M 34.44% | |
| Operating Margin | -479.68% | -492.17% | -444.00% | -3,802.79% | -4,035.30% | -2,066.57% | -453.88% | -190.34% | -50.02% | 8.04% | 44.99% | 49.77% | |
| EPS YoY % growth | N/A | -2.75 59.08% | -1.89 31.27% | -1.14 39.80% | -1.20 -5.17% | -1.38 -15.50% | -1.23 11.07% | -0.96 21.58% | -0.23 75.66% | 0.69 395.65% | 1.54 121.32% | 2.00 30.56% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -32.94% | -0.29 10.75% | -0.29 -4.73% | -0.30 -19.34% | -0.30 -5.95% |
| Revenue Q2Q % growth | 1.377M -80.90% | 1.396M 146.64% | 1.396M 160.45% | 1.396M 33.08% | 1.396M 1.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.855M -63.20% | -35.325M -12.60% | -36.636M -7.39% | -37.979M -16.42% | -39.865M -14.37% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.25 -4.17% | -0.29 | 0.04 | 14.81% |
| Q2 2024 Q2Q % growth | -0.28 45.10% | -0.29 | 0.01 | 2.95% |
| Q1 2024 Q2Q % growth | -0.32 65.59% | -0.26 | -0.06 | -22.31% |
| Q4 2023 Q2Q % growth | -0.21 73.08% | -0.30 | 0.09 | 29.01% |
| Q3 2023 Q2Q % growth | -0.24 64.18% | -0.46 | 0.22 | 47.94% |
| Q2 2023 Q2Q % growth | -0.51 19.05% | -0.79 | 0.28 | 35.65% |
| Q1 2023 Q2Q % growth | -0.93 -38.81% | -0.75 | -0.18 | -23.63% |
| Q4 2022 Q2Q % growth | -0.78 -105.26% | -0.72 | -0.06 | -8.85% |
| Q3 2022 Q2Q % growth | -0.67 16.25% | -0.73 | 0.06 | 8.77% |
| Q2 2022 Q2Q % growth | -0.63 91.81% | -0.76 | 0.13 | 17.37% |
| Q1 2022 Q2Q % growth | -0.67 | -0.74 | 0.07 | 9.40% |
| Q4 2021 Q2Q % growth | -0.38 | -0.75 | 0.37 | 49.11% |
| Q3 2021 Q2Q % growth | -0.80 | -0.65 | -0.15 | -22.55% |
| Q2 2021 Q2Q % growth | -7.69 | -2.93 | -4.76 | -162.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.049M -73.01% | 1.082M | -33K | -3.05% |
| Q2 2024 Q2Q % growth | 536K -82.97% | 2.467M | -1.931M | -78.27% |
| Q1 2024 Q2Q % growth | 566K -91.68% | 4.055M | -3.489M | -86.04% |
| Q4 2023 Q2Q % growth | 7.211M 132.61% | 3.407M | 3.804M | 111.65% |
| Q3 2023 Q2Q % growth | 3.887M 15.68% | 4.17M | -283K | -6.79% |
| Q2 2023 Q2Q % growth | 3.148M -22.46% | 4.111M | -963K | -23.42% |
| Q1 2023 Q2Q % growth | 6.803M 125.26% | 4.49M | 2.313M | 51.51% |
| Q4 2022 Q2Q % growth | 3.1M 8.77% | 3.9M | -800K | -20.51% |
| Q3 2022 Q2Q % growth | 3.36M 39.42% | 3.772M | -412K | -10.92% |
| Q2 2022 Q2Q % growth | 4.06M 42.46% | 3.063M | 997K | 32.55% |
| Q1 2022 Q2Q % growth | 3.02M 48.77% | 2.618M | 402K | 15.36% |
| Q4 2021 Q2Q % growth | 2.85M 256.25% | 3.289M | -439K | -13.35% |
| Q3 2021 Q2Q % growth | 2.41M 731.03% | 2.478M | -68K | -2.74% |
| Q2 2021 Q2Q % growth | 2.85M | 1.088M | 1.762M | 161.95% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 9.5% | 0% | 5.72% |
| Revenue | 0% | -44.48% | 0% | 0.83% |